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Understanding the Ly49 gene family can be challenging in terms of nomenclature and  
genetic organization. The Ly49 gene family has two major gene nomenclature systems,  
Ly49 and Killer Cell Lectin-like Receptor subfamily A (klra). Mice from different strains have
 
 
varying numbers of these genes with strain specific allelic variants, duplications, dele-
 
tions, and pseudogene sequences. Some members activate NK lymphocytes, invariant
 
NKT (iNKT) lymphocytes and γδT lymphocytes while others inhibit killing activity. One fam-
 
ily member, Ly49Q, is expressed only on myeloid cells and is not found on NK, iNKT, or γδ  
T cells. There is growing evidence that these receptors may regulate not just the immune  
response to viruses, but other intracellular pathogens as well. Thus, this review’s primary  
goal is to provide a guide for researchers first encountering the Ly49 gene family and a  
foundation for future studies on the role that these gene products play in the immune  
response, particularly the response to intracellular viral and bacterial pathogens.  
Keywords: Ly49, klra, natural killer lymphocytes, myeloid cells
INTRODUCTION
The highly polymorphic Ly49 genes serve as a reminder that nature
and evolution occasionally conspire to resist systematic classifi-
cation schemes. The first gene in this family was identified as a
“T lymphocyte activation marker” and became Ly49A (Chan and
Takei, 1989; Yokoyama et al., 1989). However, expression of Ly49A
is found primarily on Natural Killer (NK), invariant NK T (To
et al., 2009), and NK1.1+ γδ T lymphocytes (Hara et al., 2001).
On T lymphocytes, it is found only on a subset of CD3+ T cells
which were also NK1.1− and/or DX5− (Ortaldo et al., 1998) and
a subset of CD8+ Tregs (Kim et al., 2011). The first identified
function of the Ly49 genes was as an inhibitor of NK lymphocyte
killing of tumor cell lines that express MHC Class I. NK killing
was inhibited by Ly49A recognition of H2-Dd on the tumor cells
(Yokoyama and Seaman, 1993). It was subsequently found that
some Ly49 genes inhibited killing but others activated killing, both
via interactions with MHC Class I molecules and other molecules
like murine cytomegalovirus m157 on the surface of target cells
(Makrigiannis and Anderson, 2000). Discoveries of more genes
in the family quickly revealed that there was significant genomic
complexity in the gene family, with different strains of mice having
varying numbers of gene segments, arising in part from duplica-
tion events. Several Ly49 genomic sequences are non-functional
pseudogenes (Yokoyama and Seaman, 1993; Smith et al., 1994).
Both inhibitory and activating Ly49 have the same basic struc-
ture, with a stalk and a natural killer receptor domain (NKD).
They exist as homodimers on the surface of the cell, and interact
with ligands via the NKD structures. However, inhibitory and acti-
vating Ly49 signal differently to the cell upon recognition of their
ligands. The inhibitory Ly49 genes have a conserved Immunore-
ceptor Tyrosine-based Inhibitory motif (ITIM) domain on their
cytoplasmic tails (Belanger et al., 2008). Activating Ly49 genes
have a transmembrane arginine residue and associate with the sig-
nal adapter proteins DAP10 and DAP12. DAP12 is important for
signaling but the requirement of DAP10 for signaling is potentially
minimal (Tassi et al., 2009).
Perhaps unsurprisingly, this gene family also highlights the dif-
ferences and similarities between mice and humans. Unlike other
mammals such as rodents and cattle, the human genome does
not encode Ly49 genes (Dissen et al., 2008). Instead, humans
have the Killer Immunoglobulin-like Receptors (KIR) fulfilling
the same role, and, like the Ly49 genes, KIR are highly polymor-
phic with both activating and inhibitory receptors. The genes are
not genetically homologous to the Ly49 genes, but rather have a
parallel function (Middleton and Gonzelez, 2010), and do appear
to have evolved from similar duplication events as those seen in
the Ly49 genes (Martin et al., 2000). Accordingly, the functional
role the Ly49 genes may serve as a model to understand how KIR
participate in the immune responses of human NK cells.
GENOMICS OF THE Ly49 GENES
Soon after cloning Ly49A, southern blots and analysis of mRNA
transcripts revealed that there were several members of the Ly49
family (Yokoyama and Seaman, 1993; Smith et al., 1994), which has
subsequently expanded to include approximately 20–30 members,
including many pseudogenes (Table 1) (Makrigiannis and Ander-
son, 2000; Makrigiannis et al., 2001; Lavender and Kane, 2006;
Kielczewska et al., 2007; Scarpellino et al., 2007; Belanger et al.,
2008; Jonsson et al., 2010). This cluster was mapped to chro-
mosome 6 (Yokoyama et al., 1990), mostly in tandem as shown
in Figure 1, with the exception of Ly49B. Ly49B is also located
on Chromosome 6 but not within the Ly49 cluster. Many gene
segments, either fully functional genes or pseudogenes, are indi-
cated by the nomenclature Ly49A-Ly49X and with the strain in
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Table 1 | Combined nomenclature and ligands of the Ly49 genes.
Ly49
GenBank
Ly49 NOD Klra number Role, strain, other notes Other aliases,
previous names
or homologs
Ligands
Ly49α Pseudogene in Balb/c, NOD,
C57BL/6 (B6), and 129 mice
N/A
Ly49A Ly49a Klra1 Inhibitory. C57/BL/6 (B6),
NODShiLtJ (NOD), 129 and Balb/c
A1, Klra22, Ly49o129
(Ly49V)
H2-Dd, H2-Dr, H2-Dk, H2-Dp
(Makrigiannis and Anderson, 2000;
Scarpellino et al., 2007; Jonsson
et al., 2010). B6 strain: H2-Ld, H2-Dd
H2-Kb H2-Db (Johansson et al., 2009)
Ly49B Klra2 Inhibitory B6, 129, Balb/c. Two
isoforms (splice variants). Unique
locus 5′ from all other Ly49 genes
Klra30 Unknown
Ly49C Ly49c Klra3 Inhibitory. Balb/c, B6, and NOD,
not 129; C/I are family of four
genes; may be functional in NOD
but has early stop codon
NK2.1, SW5E6
(5E6), Nk2,
MGC123910
H2-Dd, H2-Dk, H2-Db, H2-Kb, H2-Kd,
H2-Ld, H2-Kk (Dimasi and Biassoni,
2005; Scarpellino et al., 2007;
Johansson et al., 2009). Does not
recognize CMV m157 protein
(Kielczewska et al., 2007)
Ly49D Ly49d Klra4 Activator. B6 (2 isoforms) and NOD
only
Chok, Klra32,
Ly49r129
H2-Dd, H2-Dr, H2-Dsp2 (Makrigiannis
and Anderson, 2000)
Ly49E Ly49e Klra5 Inhibitory Balb/c, NOD, B6, and
129 (Aust et al., 2011)
Urokinase plasminogen activator (Van
Den Broeck et al., 2008)
Ly49e/c Klra26, Klra27 Pseudogene 129 has Ly49ec1129,
Ly49ec2129 (Belanger et al., 2008)
N/A
Ly49F Klra6 Inhibitory NOD, B6, and 129 mice H2-Dd (Dimasi and Biassoni, 2005)
Ly49G Ly49g1=ψ;
Ly49g2= ITIM
Klra7 Pseudogene (g1NOD); Inhibitory
(g2NOD) in NOD or G in B6, Balb/c,
and 129 mice
LGL-1; MGC123448;
MGC161317
NOD H2-Kd (weak) (Scarpellino et al.,
2007); B6 strain H2-Db (Johansson
et al., 2009); 129 strain H2-Dd, H2-Dk,
H2-Kd (Makrigiannis et al., 2001);
Balb/c rat classical class I MHC
molecule, RT1-A1c (Lavender and
Kane, 2006)
Ly49H Ly49h Klra8 Activator. B6 and NOD only Cmv1, Ly49u129 CMV m157 (Arase et al., 2002;
Kielczewska et al., 2007),
H2-Db(Dimasi and Biassoni, 2005)
Ly49I Ly49i1= ITIM;
Ly49i2=ψ;
Ly49i3=ψ
Klra9 Inhibitor +2 pseudogenes in
NOD; i1 and i2 ψ in 129 mice, one i
in B6 and Balb/c
H2-Kb, H2-Kd (Scarpellino et al.,
2007); CMV m157 (Arase et al., 2002;
Kielczewska et al., 2007); 129 strain
H2-Dk, H2-Kb, H2-Kd, H2-Kk
(Makrigiannis et al., 2001) Ly49IB6
does not recognize CMV m157
protein (Kielczewska et al., 2007)
Ly49J Klra10 Pseudogene in B6 Ly49i2 N/A
Ly49K Klra11 Pseudogene B6 only Unknown
(Continued)
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Table 1 | Continued
Ly49
GenBank
Ly49 NOD Klra number Role, strain, other notes Other aliases,
previous names
or homologs
Ligands
Ly49L See Ly49pd
below
Klra12 Pseudogene Balb/c and B6
truncated
Ly49l1; Ly49l2;
Ly49l3; Ly49l4;
Ly49pd1 (see
below), Ly49pd2
(see below)
N/A
Ly49l/r Klra25 Activator (putative) 129 only
(Makrigiannis et al., 2002), not
known if expressed
Unknown
(Ly49p/d) Ly49p/d1=ψ;
Ly49p/d2=ψ
Pseudogene in NOD and 129 mice Homolog of Ly49L N/A
Ly49M Ly49m Klra13 Activator. B6 and NOD only; MGC123449 Unknown
Ly49N Klra14 Activator. Predicted gene,
homology with Klra8, Klra21
Klra29; EG654449;
OTTMUSG0000002
6959; Gm15858
Unknown
Ly49O Klra15 Inhibitor. 129 (Makrigiannis et al.,
1999) and C57L (Mehta et al., 2001)
Homolog of Ly49A in
129 mice, Ly49D in
C57L
129 Strain H2-Dk, H2-Db, H2-Dd,
H2-Ld (Makrigiannis et al., 2001)
Ly49P Ly49p1=Arg;
Ly49p2=ψ;
Ly49p3=Arg
Klra16 p1 and p3 areActivators, p2 is
pseudogene in NOD. Three genes
in NOD mice, only one in 129 mice
(Ly49P)
Ly49x (not same
gene)
H2-Dk; MCMV m04 protein
(Kielczewska et al., 2009); 129 strain,
weakly to H2-Dd, H2-Kk, H2-Ld
(Makrigiannis et al., 2001)
Ly49Q Ly49Q Klra17 Inhibitory. Balb/c, NOD, B6, and
129; q2 and q3 are ψ in 129
H2-Kb (Scarpellino et al., 2007)
Ly49R Klra18 Activator. 129 only MGC130549;
Homolog of Ly49D in
129 mice
129 Strain H2-Dk, H2-Db, H2-Dd,
H2-Ld (Makrigiannis et al., 2001)
Ly49S Klra19 Inhibitor, has unusual ITIM
(Makrigiannis et al., 2001) 129 only
129 Strain weakly to H2-Kk
(Makrigiannis et al., 2001)
Ly49T Klra20 Inhibitor. 129 only 129 Strain did not bind to any H2
tested (Makrigiannis et al., 2001)
Ly49U Ly49U Klra21 Activator. NOD and 129 only Homolog of Ly49H 129 Strain did not bind any H2 tested
(Makrigiannis et al., 2001). Does not
recognize MCMV m157 protein
(Kielczewska et al., 2007)
Ly49u/i Klra28 (see
below)
(Makrigiannis
et al., 2002)
Activator (putative) 129 only Klra11b; Ly49u/i129 Unknown
Ly49V Klra22 Inhibitory. 129 only, genomic
overlap with Klra15
129 Strain strongly to H2-Dk, H2-Db,
H2-Dd, H2-Ld weakly to H2-Kb,
H2-Kd, H2-Kk (Makrigiannis et al.,
2001)
Ly49W Ly49W Klra23 Activator. NOD only Ly49W1, Ly49W2 H2-Ld, rat classical class I MHC
molecule, RT1-A1c (Lavender and
Kane, 2006), H2-Kk, H2-Dd (Dimasi
and Biassoni, 2005)
(Continued)
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Table 1 | Continued
Ly49
GenBank
Ly49 NOD Klra number Role, strain, other notes Other aliases,
previous names
or homologs
Ligands
Ly49X Klra24 Pseudogene in NOD, and B6 mice N/A
Ly49l/r Ly49l/r Klra25 Activator (putative) 129 only
(Makrigiannis et al., 2002), not
known if expressed
Unknown
Ly49Y Pseudogene Balb/c only (Orr and
Lanier, 2011)
N/A
Klra26 Pseudogene 129 only Ly49e/c1 Unknown
Klra27 Pseudogene 129 only Ly49e/c2 Unknown
Klra28
(Makrigiannis
et al., 2002)
Activator (putative) 129 only Klra11b; Ly49u/i129 Unknown
Klra14 (Klra29) Activator. Predicted gene,
homology with Klra8, Klra21
EG654449;
OTTMUSG00000026959;
Gm15858
Unknown
Ly49B Klra30 Activator. B6, 129, Balb/c. Two
isoforms (splice variants)
Ly49b, Klra2 See Ly49B above
Klra31 Unknown
Klra32 Homolog of Ly49D? Unknown
FIGURE 1 | Genomic Organization in the four known mouse
strains. Color coded to matchTable 3 and Belanger et al. (2008).
Uppercase gene is known to be expressed. Pseudogenes indicated
with a psi symbol. Underlined sections indicate regions common in 129
and NOD mice that have also undergone duplication in NOD mice
(Belanger et al., 2008).
superscript indicating the strain allelic variants, e.g., Ly49ABalb/c,
Ly49AC57BL/6, or Ly49CC57BL/6. The first published usage of Killer
Cell Lectin-like Receptor subfamily A (Klra) introduced a different
systematic nomenclature system (Lee et al., 2001), which has been
adopted by GenBank. GenBank also uses the Ly49 nomenclature
and this can be confusing to researchers when they first encounter
these two nomenclature systems. In our opinion, the use of the
Ly49 with superscript strain nomenclature is the clearest and will
be the system used by this review. In Figure 1 and Table 2, we will
also use the shortened name, Ly49AC57BL/6 as AB6 for example.
Similarly, we believe it would be useful to instead modify the klra
nomenclature to klra1C57BL/6.
There are two other aspects of Ly49 genes that add substan-
tial complexity to their classification. Most surprisingly, different
mouse strains have different numbers of the Ly49 genes encoded
in the genome. The Makrigiannis lab has provided the best
analyses of the genomics of the Ly49 genes so far and they
found that some mouse strains, like Balb/c, have relatively few
Ly49 genes with just nine, while the Non-obese Diabetic Mouse
(NOD/ShiLtJ or NOD) strain has the most known to date with
22 Ly49 gene segments, nine of which are pseudogenes (Belanger
et al., 2008). Additionally, the same genes vary in homology from
strain to strain (Table 2; Figure 1). For example, Ly49EBalb/c is
homologous but not identical to Ly49ENOD. This diversity of
the Ly49NOD genes is very complex, due in part to duplications
and pseudogenes (Figure 1). This is shown as a separate col-
umn in Table 1 and grouped into families in Table 2. Some
of the genes have partial homology to two or more different
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genes and did not fit into the original nomenclature, for exam-
ple, Ly49p/d1NOD in Table 1, which shares partial homology with
Ly49P at exon 3 and Ly49D at exon 4. The cloning process resulted
in a few of these gene designations and were kept after com-
plete sequencing to avoid further confusion, even if other exons
showed homology to other Ly49 genes (Makrigiannis, personal
communication).
Table 2 groups the genes into related families and updates data
from a dendrogram in the NOD mouse study (Belanger et al.,
2008). We’ve expanded it to include Ly49B and two members not
included in that study, Ly49S129 and Ly49O129. Furthermore, there
have long been close relationships in homology and antigenicity
within the families, establishing groups shown in the same color
on Table 2 based on the branches of the dendrogram by Belanger
et al. (2008). A prime example of a closely related family is Ly49C,
Table 2 | Ly49 gene groups.
A group (inhibitory) aB6, a
NOD , aBalb , o129*
G group (inhibitory) t129, g1–2NOD, gB6, g129, gBalb
D group (activating) dB6, dNOD, p1–3NOD, p129, pd129, pd1–2NOD, xB6,
xNOD, r129
L group (activating) lBalb, wNOD, mB6, mNOD
C group (inhibitory) i1–2NOD, i1129, iB6, iBalb, cNOD, cBalb/c, cB6
E group (inhibitory) eNOD, eB6, e129, eBalb, fNOD, fB6, s129**
H group (activating) nB6, kB6, hB6, hNOD, uNOD, u129
Q group (inhibitory) q1129, qNOD, qB6, qBalb/c
B group (inhibitory) b129, bB6, bBalb/c
Based on homology, genomic organization, and function (Belanger et al., 2008),
groups of Ly49 genes can be clustered as above.
Ly49F, Ly49I, and Ly49H, which are recognized by some of the
same monoclonal antibodies like SW5E6 and 14B11 (Table 3).
It is important to note that the monoclonal antibody made in
one strain won’t recognize the alleles from that same strain. For
example, SW5E6 was made in 129 and won’t recognize Ly49I129
(Makrigiannis, personal communication).
There are 26 known rat Ly49 genes as well. The Ly49 genes in rat
appear to be fairly distant from the mouse homologs, with Ly49i8
showing homology to mouse Ly49B, and mouse Ly49Q somewhat
similar to a small cluster of 7 rat Ly49 genes from 26 func-
tional genes. The rat gene cluster also has numerous pseudogenes
(Nylenna et al., 2005).
LIGANDS
Many Ly49 genes recognize “self” ligands like the MHC Class
I molecules H2-D, H2-L, and H2-K (Table 1) (Makrigiannis
and Anderson, 2000; Makrigiannis et al., 2001; Dimasi and Bias-
soni, 2005; Lavender and Kane, 2006; Kielczewska et al., 2007;
Scarpellino et al., 2007; Belanger et al., 2008; Jonsson et al., 2010).
The inhibitory Ly49 receptors, like Ly49A, prevent killing upon
recognition of their cognate ligand. This is not always strain spe-
cific recognition. For example, NK cells expressing Ly49AB6, which
recognize H2-Db and H2-Kb from B6 mice, can also recognize
H2-Ld and H2-Dd which are expressed in other mouse strains
(Johansson et al., 2009). The absence of these ligands or “miss-
ing self” on target cells combined with other activating signals to
the NK lymphocyte triggers a cytolytic response by the NK cell
against the target cells. The inhibitory Ly49 genes can recognize
their ligands both in cis (on the same cell) and trans (on adjacent
cells) (Back et al., 2009) which involves a molecular shift in the
shapes of the molecules (Back et al., 2011). This has been mod-
eled with Ly49A dimers interacting with pairs of H2-D molecules
Table 3 | Expression and binding antibody clones.
Ly49 Expression Antibodies
Ly49A NK, NK T (To et al., 2009), NK1.1+ γδ (Hara et al., 2001), subset NK1.1−/DX5−/CD3+
T (Ortaldo et al., 1998); subset of CD8+Tregs (Kim et al., 2011)
12A8, A1 (B6), JR9-318 (B6, Balb/c); YE1/32, YE1/48
(Held et al., 1995)
Ly49B CD11b+/F4/80+/Gr1+ myeloid cells, activated NK, iNKT cell line, granulocytes
(neutrophils, eosinophils, mast cells) macrophages, independent of Ly49Q (Held
et al., 1995; Gays et al., 2006)
1A1 (Gays et al., 2006)
Ly49C NK, NK T (To et al., 2009), NK1.1+ γδ (Hara et al., 2001), subset NK1.1−/DX5−/CD3+
T (Ortaldo et al., 1998); subset of CD8+Tregs (Kim et al., 2011)
Ly49C/I SW5E6; Ly49C/F/I/HB6 14B11
Ly49D NK only, not on DX5−T (Ortaldo et al., 1998) 4E5; 12A1
Ly49E Fetal NK, thymic NKT (Aust et al., 2011), γδT (Van Beneden et al., 2001) Ly49E/C binds 4D12 (Van Beneden et al., 2002) CM4
(Ly49E/F) (Aust et al., 2011)
Ly49F Expression unclear (Corral et al., 1999); CD8+Tregs (Kim et al., 2011) Ly49C/I/HB6 14B11
Ly49G NK, NK T (To et al., 2009), NK1.1+ γδ (Hara et al., 2001), subset NK1.1−/DX5−/CD3+
T (Ortaldo et al., 1998); subset of CD8+Tregs (Kim et al., 2011)
4D11; Ly49G2B6 Cwy-3; Ly49G129/Balb AT8
Ly49H NK, others unknown 14B11 which recognizes Ly49C/F/I (Corral et al., 1999)
Ly49I NK, NK T (To et al., 2009), NK1.1+ γδ (Hara et al., 2001) 3D10; Ly49C/I SW5E6; Ly49C/I/F/HB6 14B11
Ly49Q Myeloid cells CD11b+/B220+/CD4+, and/or CD8+ (Toyama-Sorimachi et al., 2004);
pDCs (Kamogawa-Schifter et al., 2005); and Osteoclasts (Hayashi et al., 2010)
Ly49O NK, others unknown YE1/32, YE1/48 (Held et al., 1995)
Ly49V NK 4E 5
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in trans via an open conformation of the NKD interacting with
β2 microglobulin and the α3 domain of H2-Dd on adjacent cells.
This sends inhibitory signals to the NK cell. In cis conformations,
the NKD dimers of Ly49C can interact with one H2-Kb in a closed
conformation and, by inhibiting this inhibitory molecule, decreas-
ing the activation threshold of the NK cell (Dam et al., 2003; Held
and Mariuzza, 2008; Back et al., 2009, 2011).
Many activating Ly49 receptors also bind to MHC Class I
molecules (Dimasi and Biassoni, 2005), but this is primarily
recognition of different strain alleles or “non-self/altered-self”
MHC molecules, and is defined using allogenic cytotoxic assays
used to characterize the function of these receptors in vitro. In
addition to recognition of mouse surface proteins, Ly49WNOD
and Ly49GBalb/c can xenogenically recognize the rat class I MHC
molecule, RT1-A1c (Lavender and Kane, 2006). Ly49DB6 can be
activated by Chinese hamster ovary (CHO) cells by a molecule
mapped to the chok locus. The closely related C57L strain of mice
also seems to interact with CHO cells using Ly49OC57L which is
very homologous to Ly49DB6 and reacts to the 4E4 antibody, yet
is an inhibitory Ly49 (Mehta et al., 2001).
There is substantial evidence for tolerance and restriction by
self MHC Class I molecules and regulating development (“licens-
ing”) of NK cells via specific Ly49 genes (Lowin-Kropf et al., 2000;
Kim et al., 2005). Studies using NK cells expressing single Ly49
molecules combined with transgenic expression of single MHC
Class I ligands showed that Ly49 binding is not restricted as origi-
nally thought. Instead, many Ly49 molecules can recognize several
different MHC class I molecules (Brodin et al., 2012). Belanger
et al. (2008) have also used transgenic mice in which the Ly49O
gene was targeted. They discovered that disruption of Ly49O unin-
tentionally lowered transcription of all Ly49 genes. NK cells from
these Ly49-knockdown mice were tested for killing against cells
expressing or lacking MHC Class I genes in vivo and in vitro. It
was found that killing of cells lacking MHC Class I was impaired
by NK cells from these mice and could be rescued by restoring
Ly49I expression, which is a strong inhibitory receptor for both
H-2Kb and H-2Db, but not by restoring Ly49A or Ly49G (Cheng
et al., 2008).
Many viruses, such as those in the herpes family, inhibit sur-
face expression of MHC Class I molecules as a way of preventing
recognition by conventional cytotoxic CD8+, αβ T cell receptor+
T lymphocytes (Loch and Tampe, 2005). Although this allows
the virus to hide in the cell from these classical T lymphocytes,
infected cells are vulnerable to killing by NK cells. When acti-
vating Ly49 receptors recognize their viral ligands, such as the
mouse herpes virus cytomegalovirus (MCMV) protein m157 by
Ly49H, this triggers a cytolytic response in the NK cells against
the infected cells (Dimasi and Biassoni, 2005). MCMV protein
m157 is a ligand for Ly49HB6, Ly49HNOD/, and Ly49I129 (Arase
et al., 2002). However, similar genes from different strains of mice,
Ly49IB6 for example, do not recognize m157 (Tay et al., 1999;
Kielczewska et al., 2007). Additionally, m157 variants can escape
binding to Ly49HB6. Ly49CB6 and Ly49CBalb also can bind to
some m157 variants but these interactions do not appear to be
critical for viral resistance (Corbett et al., 2011). Ly49H seems to
be most critical for resistance to MCMV, but does not mediate
resistance to herpes simplex virus 1 or ectromelia virus (Cheng
et al., 2008). Another MCMV ligand for Ly49P is m04, which is
a viral protein that may play a role in H2-Dk stabilization (Kiel-
czewska et al., 2009). The development of memory-like NK cells,
which expand, contract, and persist like other lymphocytes, has
also been described to work, in part, via Ly49H activation via
m157. This process takes on a similar “antigen” driven expan-
sion phase which truly mimics that of the “classical” lympho-
cytes like CD8+ αβ T cell receptor+ lymphocytes (Sun et al.,
2009).
The large number of Ly49 receptors lacking known ligands
highlights another need in this field. There may be unconven-
tional ligands for some of these receptors as well. For example,
urokinase plasminogen activator has been identified as a ligand
for Ly49E and it may play a role in wound healing or tissue growth
(Van Den Broeck et al., 2008). It may be that some of the miss-
ing ligands may reveal novel functions for the Ly49 genes beyond
the simple killing of infected cells, inasmuch as a role for NK
cells in placental development has been uncovered via HLA-G and
KIR2DL4/CD158d interactions in human pregnancy (Bryceson
and Long, 2008).
CELLULAR EXPRESSION OF Ly49 GENES
Along with the lack of known ligands for many Ly49 genes, there
is very limited characterization of cells expressing Ly49 (Table 3).
Only 11 of the Ly49 receptors have monoclonal antibodies that
recognize them. Further complicating the issue, many of the
antibodies are cross-reactive for more than one Ly49 gene.
Most Ly49 genes are found on NK cells, invariant NKT (iNKT)
lymphocytes, and γδ T lymphocytes. Two of the 11 known genes
were expressed on cells other than NK cells, notably Ly49Q which
is found on myeloid cells and plasmacytoid dendritic cell (pDCs)
subsets (Kamogawa-Schifter et al., 2005), and plays a role in matu-
ration of these pDCs (Toma-Hirano et al., 2009) and activation of
osteoclasts (Hayashi et al., 2010). Ly49B also is found on CD11b+
myeloid cells including macrophages, granulocytes, and mast cells,
and there has been one report of Ly49B on activated NK and an
iNK T cell line. Expression on Ly49B and Ly49Q are on non-
overlapping myeloid subsets, and can induce in NK cells (Gays
et al., 2006). Subsets of CD8+ Tregs (as defined by CD44+,
CD122+, and Qa-1 mediated suppression) express Ly49A,Ly49C/I
(weakly), Ly49G2, but had substantial expression of Ly49F (Kim
et al., 2011).
ROLE OF Ly49 IN INFECTION
Some Ly49 genes are critical for defense against viral pathogens,
particularly MCMV (Makrigiannis and Anderson, 2000). This fits
into the paradigm of NK killing of cells that lack MHC Class
I expression due to herpes virus interference by several viral pro-
teins (Orr et al., 2005; Temme et al., 2010). Few studies have looked
at the role of Ly49 genes in other infections and in other animal
models. Depletion of cells expressing rat Ly49s3/s4/i3/i4 proteins
in rats led to increased bacterial load after infection by Listeria
monocytogenes. Furthermore, infection caused an increase in cells
expressing several different Ly49 molecules (Shegarfi et al., 2009).
Ly49G2 expression dominates early in this process in mice as well
(Barao et al., 2011). A separate study looking at Ly49 genes after
Plasmodium yoelii infection found a decrease of Ly49A, C/I, D,
and G2 expressing cells in the spleen but an increase in the liver
(Roland et al., 2006).
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Our interest in the Ly49 genes came after studying host gene
expression following infection by Francisella tularensis (Kingry
et al., 2011). A hallmark of Francisella infection is the lack of
a robust innate immune response thus allowing the bacterium
to outpace host defenses and cause rapid disseminated infection
(Hajjar et al., 2006; Bosio, 2011). The mouse model was used to
track changes in host responses during infection with the live vac-
cine strain (LVS) as well as the highly pathogenic lab strain Schu4
as measured by full genome expression microarrays. We observed
an overall decrease in expression of the Ly49G2 gene in the lungs of
Schu4 infected mice, but increased expression of Ly49G2 at 120 h
post infection in the lungs of LVS infected mice (Kingry et al.,
2011). This may signify the ability of the highly virulent strain
to evade host NK cells more efficiently than the LVS. Both the
LVS and Schu4 strain caused widespread decreases in many other
Ly49 genes in the spleen, particularly Ly49A, Ly49I, Ly 49H, and
Ly49D. Ly49D expression in the spleen eventually increased follow-
ing infection but only after extensive dissemination of both strains
of the bacteria. Ly49A, D, and H are all activating receptors, while
Ly49G and I are inhibitory receptors. These results are similar to
what was observed with Listeria and Plasmodium species (Roland
et al., 2006; Shegarfi et al., 2009). It is unclear why both activating
and inhibitory receptors might be altered after infection but it may
represent a route of host immune evasion by Francisella or changes
in the activation potentials of NK and other Ly49 expressing cells
responding to the infection. Together with the studies on MCMV
infections, we suspect that these receptors are part of the host
response to many different types of intracellular pathogens.
SUMMARY
Starting with the complex genetics of the Ly49 genes, there remain
considerable gaps in our understanding of the precise and perhaps
interactive roles of the receptors in the immune response. Even at
a basic level, ligands and cellular expression patterns remain only
partially deciphered. While the genes were originally linked to NK
killing of tumors and recognition of viral infection, recent stud-
ies have shown roles for Ly49 on other cell types and with other
functions in myeloid cells and the innate immune response. The
likely requirements for these genes in combating intracellular viral,
bacterial, and parasitic pathogens remain relatively unexplored as
well. These intriguing results hint that there may be more func-
tions of these receptors still to be discovered, especially as more
is learned about the expression profiles and ligands of the Ly49
genes.
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